{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:01:46Z","timestamp":1788886906342,"version":"build-2803163510"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03221-2","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:53:54Z","timestamp":1770292434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Updates on niosomes in interfering nucleic acid delivery for cancer treatment: A comprehensive review and future perspectives"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-8580","authenticated-orcid":false,"given":"Reena","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen Fadhil","family":"Jasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa Abbas","family":"Al-Khafaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhas","family":"Ballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8421-3630","authenticated-orcid":false,"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3415-1865","authenticated-orcid":false,"given":"Kattela","family":"Chennakesavulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"1","key":"3221_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/clinchem\/hvad202","volume":"70","author":"SM Schwartz","year":"2024","unstructured":"Schwartz SM. Epidemiology of cancer. Clin Chem. 2024;70(1):140\u20139.","journal-title":"Clin Chem"},{"issue":"6","key":"3221_CR2","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","volume":"18","author":"X Li","year":"2021","unstructured":"Li X, Xiang J, Wang J, Li J, Wu FX, Li M. FUNmarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers. IEEE ACM Trans Comput Biol Bioinform. 2021;18(6):2483\u201391.","journal-title":"IEEE ACM Trans Comput Biol Bioinform"},{"issue":"4","key":"3221_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1021\/acs.bioconjchem.5c00037","volume":"36","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Cheng H, Jiang S, Tai W. Fc multisite conjugation and prolonged delivery of the Folate-Targeted drug conjugate EC140. Bioconjug Chem. 2025;36(4):762\u20139.","journal-title":"Bioconjug Chem"},{"issue":"12","key":"3221_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2020.101036","volume":"66","author":"DB Nandini","year":"2020","unstructured":"Nandini DB, Rao RS, Hosmani J, Khan S, Patil S, Awan KH. Novel therapies in the management of oral cancer: an update. Dis Mon. 2020;66(12):101036.","journal-title":"Dis Mon"},{"issue":"3","key":"3221_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/wvn.70048","volume":"22","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li L, Chen X, Yan Q, Hu X. The efficacy of decision aids on enhancing early cancer screening: a meta-analysis of randomized controlled trials. Worldviews Evid Based Nurs. 2025;22(3):e70048.","journal-title":"Worldviews Evid Based Nurs"},{"issue":"4","key":"3221_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.7150\/ijbs.78535","volume":"19","author":"XP Li","year":"2023","unstructured":"Li XP, Qu J, Teng XQ, Zhuang HH, Dai YH, Yang Z, et al. The emerging role of super-enhancers as therapeutic targets in the digestive system tumors. Int J Biol Sci. 2023;19(4):1036\u201348.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3221_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","volume":"12","author":"ER Malone","year":"2020","unstructured":"Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med. 2020;12(1):8.","journal-title":"Genome Med"},{"issue":"2","key":"3221_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1574893616666210708143556","volume":"17","author":"Z Ye","year":"2022","unstructured":"Ye Z, Zhang Y, Liang Y, Lang J, Zhang X, Zang G, et al. Cervical cancer metastasis and recurrence risk prediction based on deep convolutional neural network. Curr Bioinform. 2022;17(2):164\u201373.","journal-title":"Curr Bioinform"},{"key":"3221_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29194737","author":"M Lee","year":"2024","unstructured":"Lee M, Lee M, Song Y, Kim S, Park N. Recent advances and prospects of nucleic acid therapeutics for anti-cancer therapy. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29194737.","journal-title":"Molecules"},{"key":"3221_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102278","volume":"35","author":"X Wang","year":"2025","unstructured":"Wang X, Sun K, Dong J, Ge Y, Liu H, Jin X, et al. Carrier-free nanoparticles based on natural products trigger dual \u201csynergy and attenuation\u201d for enhanced phototherapy of liver cancer. Mater Today Bio. 2025;35:102278.","journal-title":"Mater Today Bio"},{"key":"3221_CR11","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S466042","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xu Y, Song J, Liu X, Liu S, Yang N, et al. Tumor cell-targeting and tumor microenvironment-responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer. Int J Nanomed. 2024;19:5837\u201358.","journal-title":"Int J Nanomed"},{"issue":"7","key":"3221_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.70279","volume":"39","author":"H Rashidzadeh","year":"2025","unstructured":"Rashidzadeh H, Gharbavi M, Ghorbani R, Nazari M, Noei H, Johari B. Co-encapsulated niosomes with metformin and silver nanoparticles as potential anticancer tool for the combined therapy on lung cancer cells. Appl Organomet Chem. 2025;39(7):e70279.","journal-title":"Appl Organomet Chem"},{"issue":"2","key":"3221_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.32604\/or.2023.043576","volume":"32","author":"B Johari","year":"2023","unstructured":"Johari B, Parvinzad Leilan M, Gharbavi M, Mortazavi Y, Sharafi A, Rezaeejam H. Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells. Oncol Res. 2023;32(2):309\u201323.","journal-title":"Oncol Res"},{"key":"3221_CR14","doi-asserted-by":"publisher","first-page":"124747","DOI":"10.1016\/j.ijpharm.2024.124747","volume":"666","author":"P Kaur","year":"2024","unstructured":"Kaur P, Muskan, Kriplani P. Quality by design for Niosome-Based nanocarriers to improve transdermal drug delivery from lab to industry. Int J Pharm. 2024;666:124747.","journal-title":"Int J Pharm"},{"key":"3221_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117844","volume":"183","author":"H Teimouri","year":"2025","unstructured":"Teimouri H, Taheri S, Saidabad FE, Nakazato G, Maghsoud Y, Babaei A. New insights into gold nanoparticles in virology: a review of their applications in the prevention, detection, and treatment of viral infections. Biomed Pharmacother. 2025;183:117844.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3221_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/2211738511666230309104323","volume":"11","author":"S Sharma","year":"2023","unstructured":"Sharma S, Kumari N, Garg D, Chauhan S. A compendium of bioavailability enhancement via niosome technology. Pharm Nanotechnol. 2023;11(4):324\u201338.","journal-title":"Pharm Nanotechnol"},{"key":"3221_CR17","doi-asserted-by":"publisher","first-page":"122801","DOI":"10.1016\/j.biomaterials.2024.122801","volume":"313","author":"L Zhang","year":"2025","unstructured":"Zhang L, Shi J, Zhu MH, Huang Y, Lu Q, Sun P, et al. Liposomes-enabled cancer chemoimmunotherapy. Biomaterials. 2025;313:122801.","journal-title":"Biomaterials"},{"issue":"13","key":"3221_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2217\/nnm-2022-0045","volume":"17","author":"SKS Nguyen","year":"2022","unstructured":"Nguyen SKS, Goyal V, Gupta M. Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer. Nanomed Lond. 2022;17(13):935\u201358.","journal-title":"Nanomed Lond"},{"issue":"6","key":"3221_CR19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s40995-024-01731-8","volume":"48","author":"L Aghamohseni","year":"2024","unstructured":"Aghamohseni L, Barzegarian K, Ferdowsinia M, Mousavi-Niri N, Naseroleslami M. DNAzyme loaded nano-niosomes confer anti-cancer effects in the human breast cancer MCF-7 cells by inhibiting apoptosis, inflammation, and c-Myc\/cyclin D1. Iran J Sci. 2024;48(6):1397\u2013410.","journal-title":"Iran J Sci"},{"issue":"1","key":"3221_CR20","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/21691401.2018.1489271","volume":"47","author":"M Hemati","year":"2019","unstructured":"Hemati M, Haghiralsadat F, Yazdian F, Jafari F, Moradi A, Malekpour-Dehkordi Z. Development and characterization of a novel cationic pegylated niosome-encapsulated forms of doxorubicin, Quercetin and SiRNA for the treatment of cancer by using combination therapy. Artif Cells Nanomed Biotechnol. 2019;47(1):1295\u2013311.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"7","key":"3221_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1208\/s12249-024-02906-7","volume":"25","author":"SM Ahmadi","year":"2024","unstructured":"Ahmadi SM, Seyedabadi M, Ebrahimnejad P, Abasi M, Nokhodchi A. Efficient delivery of gold nanoparticles and miRNA-33a via cationic pegylated niosomal formulation to MCF-7 breast cancer cells. AAPS PharmSciTech. 2024;25(7):213.","journal-title":"AAPS PharmSciTech"},{"issue":"30","key":"3221_CR22","doi-asserted-by":"publisher","first-page":"20082","DOI":"10.1039\/C7CP03751A","volume":"19","author":"TP de Souza","year":"2017","unstructured":"de Souza TP, Bossa GV, Stano P, Steiniger F, May S, Luisi PL, et al. Vesicle aggregates as a model for primitive cellular assemblies. Phys Chem Chem Phys. 2017;19(30):20082\u201392.","journal-title":"Phys Chem Chem Phys"},{"issue":"6","key":"3221_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bpj.2023.01.031","volume":"122","author":"M Mihailescu","year":"2023","unstructured":"Mihailescu M, Worcester DL, Carroll CL, Chamberlin AR, White SH. DOTAP: structure, hydration, and the counterion effect. Biophys J. 2023;122(6):1086\u201393.","journal-title":"Biophys J"},{"issue":"3","key":"3221_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2174\/0118722105259776231002071218","volume":"19","author":"S Saharawat","year":"2025","unstructured":"Saharawat S, Verma S. A comprehensive review on recent advances and patents of niosomes. Recent Pat Nanotechnol. 2025;19(3):364\u201380.","journal-title":"Recent Pat Nanotechnol"},{"issue":"2","key":"3221_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijpharm.2011.11.032","volume":"423","author":"VB Junyaprasert","year":"2012","unstructured":"Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D. Physicochemical properties and skin permeation of span 60\/Tween 60 niosomes of ellagic acid. Int J Pharm. 2012;423(2):303\u201311.","journal-title":"Int J Pharm"},{"key":"3221_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122662","author":"L Maurizi","year":"2022","unstructured":"Maurizi L, Forte J, Ammendolia MG, Hanieh PN, Conte AL, Relucenti M, et al. Effect of ciprofloxacin-loaded niosomes on Escherichia coli and Staphylococcus aureus biofilm formation. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14122662.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3221_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/jpp\/rgae146","volume":"77","author":"SN Abdeljaber","year":"2025","unstructured":"Abdeljaber SN, Aljabali AA, Altrad B, Obeid MA. Silencing c-myc gene by SiRNA delivered by cationic niosomes in MCF-7 cells. J Pharm Pharmacol. 2025;77(5):658\u201367.","journal-title":"J Pharm Pharmacol"},{"key":"3221_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/978-1-0716-1205-7_42","volume":"2265","author":"MA Obeid","year":"2021","unstructured":"Obeid MA, Alyamani H, Amawi H, Aljabali AAA, Rezigue M, Abdeljaber SN, et al. SiRNA delivery to melanoma cells with cationic niosomes. Methods Mol Biol. 2021;2265:621\u201334.","journal-title":"Methods Mol Biol"},{"key":"3221_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040550","author":"S Pengnam","year":"2021","unstructured":"Pengnam S, Plianwong S, Patrojanasophon P, Radchatawedchakoon W, Yingyongnarongkul B-e, Opanasopit P, et al. Synergistic effect of doxorubicin and siRNA-mediated silencing of Mcl-1 using cationic niosomes against 3D MCF-7 spheroids. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13040550.","journal-title":"Pharmaceutics"},{"key":"3221_CR30","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S211844","author":"M Hemati","year":"2019","unstructured":"Hemati M, Haghiralsadat F, Jafary F, Moosavizadeh S, Moradi A. Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes. Int J Nanomedicine. 2019. https:\/\/doi.org\/10.2147\/IJN.S211844.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"3221_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/08982104.2018.1531424","volume":"29","author":"MA Obeid","year":"2019","unstructured":"Obeid MA, Duf\u00e8s C, Somani S, Mullen AB, Tate RJ, Ferro VA. Proof of concept studies for SiRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown. J Liposome Res. 2019;29(3):229\u201338.","journal-title":"J Liposome Res"},{"key":"3221_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2823-2_1","volume":"2595","author":"A Vishnoi","year":"2023","unstructured":"Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an updated overview. Methods Mol Biol. 2023;2595:1\u201312.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"3221_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10529-021-03085-2","volume":"43","author":"M Ghaffari","year":"2021","unstructured":"Ghaffari M, Kalantar SM, Hemati M, Dehghani Firoozabadi A, Asri A, Shams A, et al. Co-delivery of miRNA-15a and miRNA-16\u20131 using cationic pegylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells. Biotechnol Lett. 2021;43(5):981\u201394.","journal-title":"Biotechnol Lett"},{"key":"3221_CR34","doi-asserted-by":"crossref","unstructured":"Abtahi NA, Haghiralsadat F, Siyadatpanah A, Reza JZ, Nissapatorn V, Mahboob T, et al. The novel method for delivery miRNA-34a: A. New Cationic PEGylated Niosomal Formulation for the Treatment of Breast Cancer; 2021.","DOI":"10.21203\/rs.3.rs-650056\/v1"},{"key":"3221_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1043277","volume":"9","author":"NA Abtahi","year":"2022","unstructured":"Abtahi NA, Naghib SM, Haghiralsadat F, Akbari Edgahi M, Askari E. A comparative study on biopharmaceutical function of curcumin and miR-34a by multistimuli-responsive nanoniosome carrier: in-vitro and in-vivo. Front Mol Biosci. 2022;9:1043277.","journal-title":"Front Mol Biosci"},{"issue":"41","key":"3221_CR36","doi-asserted-by":"publisher","first-page":"9449","DOI":"10.1039\/D0TB01750G","volume":"8","author":"L Hu","year":"2020","unstructured":"Hu L, Fu X, Kong G, Yin Y, Meng HM, Ke G, et al. DNAzyme-gold nanoparticle-based probes for biosensing and bioimaging. J Mater Chem B. 2020;8(41):9449\u201365.","journal-title":"J Mater Chem B"},{"issue":"16","key":"3221_CR37","doi-asserted-by":"publisher","first-page":"8954","DOI":"10.1039\/D1CS00240F","volume":"50","author":"EM McConnell","year":"2021","unstructured":"McConnell EM, Cozma I, Mou Q, Brennan JD, Lu Y, Li Y. Biosensing with dnazymes. Chem Soc Rev. 2021;50(16):8954\u201394.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"3221_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13578-024-01213-9","volume":"14","author":"C Luo","year":"2024","unstructured":"Luo C, Yu Y, Zhu J, Chen L, Li D, Peng X, et al. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Cell Biosci. 2024;14(1):35.","journal-title":"Cell Biosci"},{"issue":"Pt 2","key":"3221_CR39","doi-asserted-by":"publisher","first-page":"147657","DOI":"10.1016\/j.ijbiomac.2025.147657","volume":"328","author":"M Sun","year":"2025","unstructured":"Sun M, Wang M, Gao H, Li L, Wu M, Li Q, et al. The interplay between post-transcriptional RNA regulation and Wnt\/\u03b2-Catenin signaling in cancer: A review. Int J Biol Macromol. 2025;328(Pt 2):147657.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"3221_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/pharmaceutics13030394","volume":"13","author":"V Maurer","year":"2021","unstructured":"Maurer V, Altin S, Ag Seleci D, Zarinwall A, Temel B, Vogt PM, et al. In-vitro application of magnetic hybrid niosomes: targeted sirna-delivery for enhanced breast cancer therapy. Pharmaceutics. 2021;13(3):394.","journal-title":"Pharmaceutics"},{"issue":"12","key":"3221_CR41","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1021\/acs.molpharmaceut.5b00692","volume":"12","author":"S Rajput","year":"2015","unstructured":"Rajput S, Puvvada N, Kumar BNP, Sarkar S, Konar S, Bharti R, et al. Overcoming Akt induced therapeutic resistance in breast cancer through siRNA and thymoquinone encapsulated multilamellar gold niosomes. Mol Pharm. 2015;12(12):4214\u201325.","journal-title":"Mol Pharm"},{"issue":"1","key":"3221_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12645-023-00175-w","volume":"14","author":"NA Abtahi","year":"2023","unstructured":"Abtahi NA, Salehi S, Naghib SM, Haghiralsadat F, Edgahi MA, Ghorbanzadeh S, et al. Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo. Cancer Nanotechnol. 2023;14(1):22.","journal-title":"Cancer Nanotechnol"},{"issue":"23","key":"3221_CR43","doi-asserted-by":"publisher","first-page":"19494","DOI":"10.1021\/acsami.8b05513","volume":"10","author":"C Yang","year":"2018","unstructured":"Yang C, Gao S, Song P, Dagn\u00e6s-Hansen F, Jakobsen M, Kjems J. Theranostic niosomes for efficient siRNA\/MicroRNA delivery and activatable near-infrared fluorescent tracking of stem cells. ACS Appl Mater Interfaces. 2018;10(23):19494\u2013503.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"3221_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1021\/mp200426h","volume":"9","author":"C Zhou","year":"2012","unstructured":"Zhou C, Mao Y, Sugimoto Y, Zhang Y, Kanthamneni N, Yu B, et al. SPANosomes as delivery vehicles for small interfering RNA (siRNA). Mol Pharm. 2012;9(2):201\u201310.","journal-title":"Mol Pharm"},{"key":"3221_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.actbio.2015.09.029","volume":"28","author":"M Sun","year":"2015","unstructured":"Sun M, Yang C, Zheng J, Wang M, Chen M, Le DQS, et al. Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense. Acta Biomater. 2015;28:171\u201382.","journal-title":"Acta Biomater"},{"issue":"1","key":"3221_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12645-022-00135-w","volume":"13","author":"NA Abtahi","year":"2022","unstructured":"Abtahi NA, Naghib SM, Haghiralsadat F, Akbari Edgahi M. Development of highly efficient niosomal systems for co-delivery of drugs and genes to treat breast cancer in vitro and in vivo. Cancer Nanotechnol. 2022;13(1):28.","journal-title":"Cancer Nanotechnol"},{"issue":"4","key":"3221_CR47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/pharmaceutics13040550","volume":"13","author":"S Pengnam","year":"2021","unstructured":"Pengnam S, Plianwong S, Patrojanasophon P, Radchatawedchakoon W, Yingyongnarongkul B-e, Opanasopit P, et al. Synergistic effect of doxorubicin and siRNA-mediated silencing of MCL-1 using cationic niosomes against 3D MCF-7 spheroids. Pharmaceutics. 2021;13(4):550.","journal-title":"Pharmaceutics"},{"key":"3221_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102424","author":"S Pengnam","year":"2023","unstructured":"Pengnam S, Opanasopit P, Rojanarata T, Yingyongnarongkul B-e, Thongbamrer C, Plianwong S. Dual-targeted therapy in HER2-overexpressing breast cancer with trastuzumab and novel cholesterol-based nioplexes silencing Mcl-1. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15102424.","journal-title":"Pharmaceutics"},{"issue":"7","key":"3221_CR49","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1021\/acs.molpharmaceut.7b00352","volume":"14","author":"MA Obeid","year":"2017","unstructured":"Obeid MA, Elburi A, Young LC, Mullen AB, Tate RJ, Ferro VA. Formulation of nonionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of SiRNA into cancer cells. Mol Pharm. 2017;14(7):2450\u20138.","journal-title":"Mol Pharm"},{"key":"3221_CR50","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S177674","author":"P Mokhtary","year":"2018","unstructured":"Mokhtary P, Javan B, Sharbatkhari M, Soltani A, Erfani-Moghadam V. Cationic vesicles for efficient shRNA transfection in the MCF-7 breast cancer cell line. Int J Nanomedicine. 2018. https:\/\/doi.org\/10.2147\/IJN.S177674.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"3221_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1263\/jbb.106.243","volume":"106","author":"M Han","year":"2008","unstructured":"Han M, Chen JL, Hu Y, He CL, Shuai WP, Yu JH, et al. In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes. J Biosci Bioeng. 2008;106(3):243\u20137.","journal-title":"J Biosci Bioeng"},{"key":"3221_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123686","volume":"235","author":"M Safari Sharafshadeh","year":"2023","unstructured":"Safari Sharafshadeh M, Tafvizi F, Khodarahmi P, Ehtesham S. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy. Int J Biol Macromol. 2023;235:123686.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"3221_CR53","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pharmaceutics16030397","volume":"16","author":"M Liu","year":"2024","unstructured":"Liu M, Svirskis D, Proft T, Loh J, Huang Y, Wen J. Cellular uptake and transport mechanism investigations of pegylated niosomes for improving the oral delivery of thymopentin. Pharmaceutics. 2024;16(3):397.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3221_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2219420","volume":"30","author":"M Mashal","year":"2023","unstructured":"Mashal M, Attia N, Grijalvo S, Eritja R, Puras G, Pedraz JL. Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers. Drug Deliv. 2023;30(1):2219420.","journal-title":"Drug Deliv"},{"issue":"10","key":"3221_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/inorganics13100337","volume":"13","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Xiang H, Tang X. Smart inorganic nanomaterials for tumor microenvironment modulation. Inorganics. 2025;13(10):337.","journal-title":"Inorganics"},{"key":"3221_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.110993","volume":"209","author":"J Li","year":"2025","unstructured":"Li J, He HG, Guan C, Ding Y, Hu X. Dynamic joint prediction model of severe radiation-induced oral mucositis among nasopharyngeal carcinoma: a prospective longitudinal study. Radiother Oncol. 2025;209:110993.","journal-title":"Radiother Oncol"},{"key":"3221_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24729","author":"H Wang","year":"2024","unstructured":"Wang H, Yang J, Li X, Zhao H. Current state of immune checkpoints therapy for glioblastoma. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24729.","journal-title":"Heliyon"},{"issue":"1","key":"3221_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00686-2","volume":"10","author":"M Nasim","year":"2024","unstructured":"Nasim M, Khan M, Parveen R, Gull A, Khan S, Ali J. Novel paradigm of therapeutic intervention for skin cancer: challenges and opportunities. Future J Pharm Sci. 2024;10(1):112.","journal-title":"Future J Pharm Sci"},{"key":"3221_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13036-019-0189-9","volume":"13","author":"L He","year":"2019","unstructured":"He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, et al. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J Biol Eng. 2019;13:58.","journal-title":"J Biol Eng"},{"key":"3221_CR60","first-page":"100095","volume":"8","author":"A Al-Jammal","year":"2022","unstructured":"Al-Jammal A, Bigdeli MR, Moghadam FM. pH-sensitive oleuropein-loaded niosome: efficient treatment for metastatic brain tumors in initial steps in-vivo. Open Nano. 2022;8:100095.","journal-title":"Open Nano"},{"issue":"3","key":"3221_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/biology10030173","volume":"10","author":"I Akbarzadeh","year":"2021","unstructured":"Akbarzadeh I, Shayan M, Bourbour M, Moghtaderi M, Noorbazargan H, Eshrati Yeganeh F, et al. Preparation, optimization and in-vitro evaluation of curcumin-loaded niosome@ calcium alginate nanocarrier as a new approach for breast cancer treatment. Biology. 2021;10(3):173.","journal-title":"Biology"},{"key":"3221_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117550","volume":"180","author":"C Xu","year":"2024","unstructured":"Xu C, Huang X, Hu Q, Xue W, Zhou K, Li X, et al. Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer. Biomed Pharmacother. 2024;180:117550.","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"3221_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411575","volume":"24","author":"L Chen","year":"2023","unstructured":"Chen L, Luo J, Zhang J, Wang S, Sun Y, Liu Q, et al. Dual targeted nanoparticles for the codelivery of Doxorubicin and siRNA cocktails to overcome ovarian cancer stem cells. Int J Mol Sci. 2023;24(14):11575.","journal-title":"Int J Mol Sci"},{"key":"3221_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34096","author":"B Johari","year":"2024","unstructured":"Johari B, Tavangar-Roosta S, Gharbavi M, Sharafi A, Kaboli S, Rezaeejam H. Suppress the cell growth of cancer stem-like cells (NTERA-2) using Sox2-Oct4 decoy oligodeoxynucleotide\u2009\u2212\u2009encapsulated niosomes-zinc hybrid nanocarriers under X-irradiation. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34096.","journal-title":"Heliyon"},{"issue":"12","key":"3221_CR65","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1021\/acs.molpharmaceut.5b00692","volume":"12","author":"S Rajput","year":"2015","unstructured":"Rajput S, Puvvada N, Kumar BP, Sarkar S, Konar S, Bharti R, et al. Overcoming Akt induced therapeutic resistance in breast cancer through SiRNA and thymoquinone encapsulated multilamellar gold niosomes. Mol Pharm. 2015;12(12):4214\u201325.","journal-title":"Mol Pharm"},{"issue":"8","key":"3221_CR66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/bios12080557","volume":"12","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Zhang H, Dong X, Lin M, Yang C. Niosome-assisted delivery of DNA fluorescent probe with optimized strand displacement for intracellular microRNA21 imaging. Biosensors. 2022;12(8):557.","journal-title":"Biosensors"},{"issue":"4","key":"3221_CR67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/nano15040285","volume":"15","author":"W Graham","year":"2025","unstructured":"Graham W, Torbett-Dougherty M, Islam A, Soleimani S, Bruce-Tagoe TA, Johnson JA. Magnetic nanoparticles and drug delivery systems for anti-cancer applications: a review. Nanomaterials. 2025;15(4):285.","journal-title":"Nanomaterials"},{"issue":"11","key":"3221_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2024.130706","volume":"1868","author":"A Wu","year":"2024","unstructured":"Wu A, Yang H, Xiao T, Gu W, Li H, Chen P. COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma. Biochimica et Biophysica Acta (BBA). 2024;1868(11):130706.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"5","key":"3221_CR69","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/polym13050791","volume":"13","author":"TM Shehata","year":"2021","unstructured":"Shehata TM, Ibrahim MM, Elsewedy HS. Curcumin niosomes prepared from proniosomal gels: in vitro skin permeability, kinetic and in vivo studies. Polymers. 2021;13(5):791.","journal-title":"Polymers"},{"key":"3221_CR70","doi-asserted-by":"crossref","unstructured":"Salehi S, Nourbakhsh MS, Yousefpour M, Rajabzadeh G, Sahab-negah S, Preparation. Physicochemical Properties, Invitro And In Vivo Release Evaluation of Chitosan Decorated Curcumin Loaded Niosome. 2021.","DOI":"10.21203\/rs.3.rs-429869\/v1"},{"key":"3221_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103648","volume":"75","author":"M Munekane","year":"2022","unstructured":"Munekane M, Kosugi A, Yamasaki M, Watanabe Y, Kannaka K, Sano K, et al. Biodistribution study of indium-111-labeled PEGylated niosomes as novel drug carriers for tumor-targeting. J Drug Deliv Sci Technol. 2022;75:103648.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"3221_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-021-06623-6","volume":"32","author":"M Barani","year":"2021","unstructured":"Barani M, Hajinezhad MR, Sargazi S, Rahdar A, Shahraki S, Lohrasbi-Nejad A, et al. In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes. J Mater Sci Mater Med. 2021;32(12):147.","journal-title":"J Mater Sci Mater Med"},{"key":"3221_CR73","unstructured":"Yang H, Zhu S, Wei H, Huang W, Chen Q, He Y et al. TsRNADisease: a manually curated database of TsRNAs associated with human disease. J Genet Genomics. 2025;S1673-8527(25)00223-1."},{"issue":"9","key":"3221_CR74","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00210-023-02467-9","volume":"396","author":"M Naseroleslami","year":"2023","unstructured":"Naseroleslami M, Mousavi Niri N, Hosseinian SB, Aboutaleb N. DNAzyme loaded nano-niosomes attenuate myocardial ischemia\/reperfusion injury by targeting apoptosis, inflammation in a NF-\u03baB dependent mechanism. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(9):2127\u201336.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"3221_CR75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/08982104.2020.1768110","volume":"31","author":"MA Obeid","year":"2021","unstructured":"Obeid MA, Teeravatcharoenchai T, Connell D, Niwasabutra K, Hussain M, Carter K, et al. Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses. J Liposome Res. 2021;31(2):195\u2013202.","journal-title":"J Liposome Res"},{"key":"3221_CR76","first-page":"337","volume-title":"Liposomes and niosomes for targeted drug and gene delivery systems","author":"MZ Ahmad","year":"2022","unstructured":"Ahmad MZ, Bhatnagar D, Ladhe S, Kumar D, Pathak K, Das RJ, et al. Liposomes and niosomes for targeted drug and gene delivery systems. Pharmaceutical Nanobiotechnology for Targeted Therapy: Springer; 2022. pp. 337\u201359."},{"key":"3221_CR77","doi-asserted-by":"publisher","first-page":"10283","DOI":"10.2147\/IJN.S480639","volume":"19","author":"S Gao","year":"2024","unstructured":"Gao S, Sui Z, Jiang Q, Jiang Y. Functional evaluation of niosomes utilizing surfactants in nanomedicine applications. Int J Nanomed. 2024;19:10283\u2013305.","journal-title":"Int J Nanomed"},{"key":"3221_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114829","volume":"254","author":"AG Niculescu","year":"2025","unstructured":"Niculescu AG, Dumitrascu AM, Ko\u00e7er AT, Aray\u0131c\u0131 PP, Yuka SA, Ko\u00e7er S, et al. Nanotechnology-driven enhancement and modulation of immune responses in monkeypox and respiratory syncytial virus nanovaccine research. Colloids Surf B Biointerfaces. 2025;254:114829.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3221_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17111473","author":"A Ababei-Bobu","year":"2025","unstructured":"Ababei-Bobu A, Profire B, Iacob AT, Chirliu OM, Lupa\u0219cu FG, Profire L. Niosomes as vesicular carriers: from formulation strategies to stimuli-responsive innovative modulations for targeted drug delivery. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17111473.","journal-title":"Pharmaceutics"},{"issue":"30","key":"3221_CR80","doi-asserted-by":"publisher","first-page":"34011","DOI":"10.1021\/acsami.0c05489","volume":"12","author":"N Kimura","year":"2020","unstructured":"Kimura N, Maeki M, Sato Y, Ishida A, Tani H, Harashima H, et al. Development of a microfluidic-based post-treatment process for size-controlled lipid nanoparticles and application to SiRNA delivery. ACS Appl Mater Interfaces. 2020;12(30):34011\u201320.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"3221_CR81","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1021\/acssynbio.1c00371","volume":"10","author":"R Tivony","year":"2021","unstructured":"Tivony R, Fletcher M, Al Nahas K, Keyser UF. A microfluidic platform for sequential assembly and separation of synthetic cell models. ACS Synth Biol. 2021;10(11):3105\u201316.","journal-title":"ACS Synth Biol"},{"issue":"91","key":"3221_CR82","doi-asserted-by":"publisher","first-page":"87910","DOI":"10.1039\/C6RA19525C","volume":"6","author":"DA Seleci","year":"2016","unstructured":"Seleci DA, Seleci M, Jochums A, Walter J-G, Stahl F, Scheper T. Aptamer mediated niosomal drug delivery. RSC Adv. 2016;6(91):87910\u20138.","journal-title":"RSC Adv"},{"issue":"33","key":"3221_CR83","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1039\/C8TB01563E","volume":"6","author":"C Riccardi","year":"2018","unstructured":"Riccardi C, Fabrega C, Grijalvo S, Vitiello G, D\u2019Errico G, Eritja R, et al. AS1411-decorated niosomes as effective nanocarriers for Ru (III)-based drugs in anticancer strategies. J Mater Chem B. 2018;6(33):5368\u201384.","journal-title":"J Mater Chem B"},{"key":"3221_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194696","author":"D Ag Seleci","year":"2019","unstructured":"Ag Seleci D, Maurer V, Stahl F, Scheper T, Garnweitner G. Rapid microfluidic preparation of niosomes for targeted drug delivery. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20194696.","journal-title":"Int J Mol Sci"},{"issue":"26","key":"3221_CR85","doi-asserted-by":"publisher","first-page":"16359","DOI":"10.1021\/acsnano.4c01790","volume":"18","author":"F Branco","year":"2024","unstructured":"Branco F, Cunha J, Mendes M, Vitorino C, Sousa JJ. Peptide-hitchhiking for the development of nanosystems in glioblastoma. ACS Nano. 2024;18(26):16359\u201394.","journal-title":"ACS Nano"},{"issue":"12","key":"3221_CR86","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc A, Maier MA, Manoharan M, Fitzgerald K, Jayaraman M, Barros S, et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol. 2019;14(12):1084\u20137.","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"3221_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1856","volume":"15","author":"MA Sufian","year":"2023","unstructured":"Sufian MA, Ilies MA. Lipid-based nucleic acid therapeutics with in vivo efficacy. WIREs Nanomed Nanobiotechnol. 2023;15(2):e1856.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"issue":"9","key":"3221_CR88","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/17425247.2018.1517747","volume":"15","author":"D Wang","year":"2018","unstructured":"Wang D, Sun Y, Liu Y, Meng F, Lee RJ. Clinical translation of immunoliposomes for cancer therapy: recent perspectives. Expert Opin Drug Deliv. 2018;15(9):893\u2013903.","journal-title":"Expert Opin Drug Deliv"},{"key":"3221_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109022","volume":"111","author":"M Barati","year":"2022","unstructured":"Barati M, Mirzavi F, Atabaki M, Bibak B, Mohammadi M, Jaafari MR. A review of PD-1\/PD-L1 siRNA delivery systems in immune T cells and cancer cells. Int Immunopharmacol. 2022;111:109022.","journal-title":"Int Immunopharmacol"},{"key":"3221_CR90","first-page":"279","volume-title":"Nanotechnology Based Strategies for Cancer Immunotherapy: Concepts, Design, and Clinical Applications","author":"S Raikwar","year":"2025","unstructured":"Raikwar S, Vishwakarma N, Sharma S, Sharma R, Jain SK. Polymer\/Lipid-Based Nanocomplexes in Cancer Immunotherapy. In: Nanotechnology Based Strategies for Cancer Immunotherapy: Concepts, Design, and Clinical Applications. Springer; 2025. p. 279\u2013300."}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03221-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03221-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03221-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:02:20Z","timestamp":1775653340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03221-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":90,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["3221"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03221-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"ChatGPT4o and DeepSeek3.2 were used for language editing, grammatical check, and text refinement. Authors approved all sections of article and accept the correspondence of all contents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI"}}],"article-number":"130"}}